PatientsVisitorsLocations & ServicesAbout the RegionJoin Our TeamPhysicians
Find:  Locations | Services
Pathology and Laboratory Medicine HomeTest and Services CatalogueTransfusion Medicine Product CataloguePolicy and ProcedureJob AidsSpecimen Collection and TransportRequisitionsAntibiogramsGenetic Testing and Molecular GeneticsMicrobiology EssentialsTransfusion EssentialsReference RangesLaboratory SuppliesAcute Care SCM GuidelinesContact InformationPhysician Access to Patient ResultsOpening A New Clinic
Pathology and Laboratory Medicine
Product Catalogue

​Anti-Inhibitor Coagulant Complex

Transfusion Medicine

​Alternate Product Names
  • ​Factor Eight Inhibitor Bypassing Agent
  • FEIBA
​Indications
  • ​Prevention and control of bleeding episodes in patients with Hemophilia A and B who have developed inhibitors
  • Management of severe or life-threatening dabigatran (Pradaxa®) associated bleeding in the absence of Praxbind®  (off-label use)
​Resource Information

​Product Monograph:

Product Information:

Size/Volume Available
  • FEIBA NF® (Anti-Inhibitor Coagulant Complex)
    • Volume Available: 1000 IU
  • Products not listed may be available through Canadian Blood Services Regina by contacting Transfusion Medicine or your site laboratory
Availability
​RUH​SCH​SPH​Rural
​Yes​No​No​No
  • ​SCH and SPH requests will be transported from RUH as requests are received
Pretransfusion Testing Requirements
  • ​None required
Forms Required

​Saskatoon:

Ordering
  • Specify dosage required
  • Requests for management of severe or life-threatening dabigatran (Pradaxa®) associated bleeding or anyone other than bleeding disorders patients must be cleared by the on-call Transfusion Medicine Physician
​Notes
​Administration
  • ​See Notes
  • Contains human protein; informed patient consent required for this product

 

​If you choose to print this information, it is valid only on date of print.

Laboratory Controlled Document LSM-49 v4

Last Modified: Thursday, February 7, 2019 |
Questions or feedback about this page?